Shakeel Virk

机构：Queen's University · ORCID：0009-0002-4648-3514

发表论文 61 篇 · 总被引 605 次 · h-index 9

代表论文

An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer (2018 · Modern Pathology · 被引 99)
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer (2017 · JAMA Oncology · 被引 60)
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study (2022 · Modern Pathology · 被引 54)
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab) (2017 · Breast Cancer Research and Treatment · 被引 23)
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial (2024 · Clinical Cancer Research · 被引 20)
Abundant expression of BMI1 in follicular lymphoma is associated with reduced overall survival (2017 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 8)